Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 02 symbols : RETA save search
Replimune Appoints Christy Oliger to its Board of Directors
Published: 2021-12-02 (Crawled : 19:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
REPL | $6.32 -1.56% -1.58% 630K
|
Health Technology
|
| O: -0.46%
H: 4.77%
C: 3.95%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.27%
H: 3.46%
C: -5.38%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -0.43%
H: 4.0%
C: 4.0%
CNS Pharmaceuticals Receives Approval from Switzerland Ethics Committee for its Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2021-12-02 (Crawled : 15:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.27%
H: 3.46%
C: -5.38%
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 10.38%
H: 0.0%
C: -8.55%
treatment approval berubicin potential switzerland glioblastoma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.